article thumbnail

Merck settles with insurers regarding a $1.4 billion claim over NotPetya damages

Security Affairs

known as Merck Sharp & Dohme (MSD) outside the United States and Canada, is an American multinational pharmaceutical company. It is one of the largest pharmaceutical companies globally, engaged in the research, development, manufacturing, and marketing of a wide range of healthcare products. Merck & Co.,

Insurance 111
article thumbnail

Why IDMP compliance requires adaptive data governance

Collibra

Pharmaceutical, biotech and medical devices firms, among others, must comply with a plethora of regulations. This requires every company to perform gap analysis to determine what is required and then update their systems, processes, workflows and data management strategy accordingly to ensure compliance.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Pharmaceutical Company to Plead Guilty and Settle Drug Marketing Charges

Hunton Privacy

Recently, Aegerion Pharmaceuticals announced that it will enter into several settlements and plead guilty to two misdemeanors in connection with alleged violations of HIPAA, drug marketing regulations and securities laws. The criminal charges stem from the company’s marketing of a cholesterol drug called Juxtapid.

article thumbnail

Driving innovation and growth, Reltio powers into 2024

Reltio

It enables the setting of grouping rules by attributes like last name and address, continuously updates household members based on new data, and integrates with Salesforce for dynamic household member management, benefiting marketing and customer service initiatives. The velocity packs epitomize Reltio’s mission to provide fast time-to-value.

article thumbnail

Optimizing clinical trial site performance: A focus on three AI capabilities

IBM Big Data Hub

Despite advancements in the pharmaceutical industry and biomedical research, delivering drugs to market is still a complex process with tremendous opportunity for improvement. The ability to seize these advantages is one way that pharmaceutical companies may be able to gain sizable competitive edge.

article thumbnail

Enterprise Architecture: Secrets to Success

erwin

Here are some of the issues and questions being raised: Growth : How do we define growth strategies (e.g., M&A, new markets, products and businesses). Emerging Markets : What opportunities align to our business (e.g., operating strategy, global business services and shared services)? big data, analytics and insights)?

article thumbnail

Customer Experience Trends: How To Stand Out From the Crowd

Reltio

It’s no longer a matter of having just the best product, the smartest marketing, or the lowest prices. According to Gartner , “more than two-thirds of marketers responsible for CX say their companies compete mostly on the basis of CX, and in two years 81% expect to be competing mostly or completely on the basis of CX.”.